Out-of-pocket expenses by years since diagnosis of diabetes and severity of diabetes over the past 12 months.</p
Diabetes-related costs for participants enrolled in 2018 and 2019 (log scale).</p
<p>Out-of-pocket health expenditure as a percentage of total expenditure on health, 1995–2011 (Based...
Objective: To assess the determinants of out-of-pocket (OOP) expenses on diabetes-related treatment ...
Consultations with health care practitioners by years since diagnosis of diabetes and severity of di...
Out-of-pocket expenditures (in INR#) for healthcare payments and catastrophic health expenditures by...
Expenditure on and access to antidiabetic, antihypertensive and antilipidemic drugs, FY 2010–2012.</...
Use of complementary health products and practices by years since diagnosis of diabetes and severity...
<p>Breakdown of cost among individuals with and without diabetes from base-case analysis (in 2012US$...
OBJECTIVEWe assessed the excess medical expenditures for adults newly diagnosed with diabetes, for u...
<p>The cumulative rate of diabetic complications with the period preset to 30 years.</p
<p>Decile expenditure ratio and cumulative out-of-pocket (OOP) health payments 2010.</p
ObjectiveHigh out-of-pocket (OOP) costs can be an obstacle to health care access and treatment compl...
<p>Patient costs of managing complications of hypertension and diabetes (2017 US dollars).</p
<p>Direct costs refer to those incurred for medical treatment (vaccine, RIG, tetanus immunization an...
Background: Globally, noncommunicable diseases (NCD) demand a higher healthcare expenditure. Among N...
Diabetes-related costs for participants enrolled in 2018 and 2019 (log scale).</p
<p>Out-of-pocket health expenditure as a percentage of total expenditure on health, 1995–2011 (Based...
Objective: To assess the determinants of out-of-pocket (OOP) expenses on diabetes-related treatment ...
Consultations with health care practitioners by years since diagnosis of diabetes and severity of di...
Out-of-pocket expenditures (in INR#) for healthcare payments and catastrophic health expenditures by...
Expenditure on and access to antidiabetic, antihypertensive and antilipidemic drugs, FY 2010–2012.</...
Use of complementary health products and practices by years since diagnosis of diabetes and severity...
<p>Breakdown of cost among individuals with and without diabetes from base-case analysis (in 2012US$...
OBJECTIVEWe assessed the excess medical expenditures for adults newly diagnosed with diabetes, for u...
<p>The cumulative rate of diabetic complications with the period preset to 30 years.</p
<p>Decile expenditure ratio and cumulative out-of-pocket (OOP) health payments 2010.</p
ObjectiveHigh out-of-pocket (OOP) costs can be an obstacle to health care access and treatment compl...
<p>Patient costs of managing complications of hypertension and diabetes (2017 US dollars).</p
<p>Direct costs refer to those incurred for medical treatment (vaccine, RIG, tetanus immunization an...
Background: Globally, noncommunicable diseases (NCD) demand a higher healthcare expenditure. Among N...
Diabetes-related costs for participants enrolled in 2018 and 2019 (log scale).</p
<p>Out-of-pocket health expenditure as a percentage of total expenditure on health, 1995–2011 (Based...
Objective: To assess the determinants of out-of-pocket (OOP) expenses on diabetes-related treatment ...
DOI
Add to ORKG